系统综述与荟萃分析:国际标准化比值异常与肝硬化患者围手术期出血事件不相关
该系统综述与荟萃分析纳入29项研究、13 276例接受指示性操作的肝硬化患者,评估术前国际标准化比值(INR)与围手术期出血事件的关系。结果显示围手术期出血事件与术前INR无显著关联(合并OR 1.52;95%CI 0.99, 2.33;P=0.06),出血与未出血患者平均INR也无显著差异(合并均数差0.05;95%CI -0.03, 0.13;P=0.23)。作者结论认为INR不能作为肝硬化患者围手术期出血事件的显著相关指标。
要点
- 围手术期出血事件与术前INR无显著关联(合并OR 1.52;95%CI 0.99, 2.33;P=0.06)。
- 出血与未出血患者平均INR无显著差异(合并均数差0.05;95%CI -0.03, 0.13;P=0.23)。
- 部分研究存在显著异质性,主要源于特定操作类型的显著亚组效应,且各研究输血实践明显不一致。
核心结论
- INR不能作为肝硬化患者围手术期出血事件的显著相关指标。
- 作者希望这些新发现能作为未来研究的跳板,并尽量减少血制品输注,因血制品在肝硬化患者中可带来众多不良反应。
研究设计与样本
- 系统综述与荟萃分析,经全面数据库检索原始文献后,纳入29项研究,共13 276例接受指示性操作的肝硬化患者。
主要发现
- 围手术期出血事件与术前INR无显著关联(合并OR 1.52;95%CI 0.99, 2.33;P=0.06)。
- 出血与未出血患者平均INR无显著差异(合并均数差0.05;95%CI -0.03, 0.13;P=0.23)。
- 部分研究存在显著异质性,主要源于特定操作类型的显著亚组效应,且各研究输血实践明显不一致。
关键数值与推荐
- 围手术期出血事件与术前INR:合并OR 1.52(95%CI 0.99, 2.33;P=0.06)。
- 出血与未出血患者平均INR:合并均数差0.05(95%CI -0.03, 0.13;P=0.23)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 部分研究存在显著异质性,主要源于特定操作类型的显著亚组效应。
- 各研究输血实践明显不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cirrhotic coagulopathy is a delicate interplay comprising deficiencies of both procoagulant and anticoagulant factors. AIM: To identify the relationship between international normalised ratio [INR] with periprocedural bleeding risk among patients with cirrhosis. METHODS: Following a thorough database search of the primary literature, 29 studies were targeted for analysis, including 13 276 patients with cirrhosis undergoing indicated procedures. RESULTS: There was no significant association between periprocedural bleeding events and pre-procedural INR [pooled odds ratio 1.52; 95% CI 0.99, 2.33; P = 0.06]. Furthermore, there was no significant difference in mean INR [pooled mean difference 0.05; 95% CI -0.03, 0.13; P = 0.23] upon comparison of patients who either did or did not experience a periprocedural bleeding event. Significant heterogeneity among some studies was primarily fuelled by significant subgroup effects of both specific procedure types performed. Additionally, there were markedly inconsistent transfusion practices across studies. CONCLUSIONS: INR fails to serve as a significant correlate for periprocedural bleeding events among patients with cirrhosis. Ideally, these new findings will help serve as a springboard for future studies, as well as to minimize transfusion of blood products, which command a myriad of adverse effects among patients with cirrhosis.
引用
- Kovalic AJ, Majeed CN, Samji NS, et al. Systematic review with meta-analysis: abnormalities in the international normalised ratio do not correlate with periprocedural bleeding events among patients with cirrhosis. Aliment Pharmacol Ther. 2020. PMID: 33105981. doi:10.1111/apt.16078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。